Nosis Bio is a biotechnology company that uses deep learning and novel, highly multiplexed biochemistry assays to design new molecules that turn therapies into highly targeted treatments. They aim to solve the drug delivery problem with a mission to create truly programmable therapeutics that will lead to many new treatments across a number of different diseases.